drugset / Trial / NCT00790738
Liothyronine (T3) for Bipolar Depression
Phase 3
Completed
11 enrolled
Northwell Health
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the efficacy of the thyroid hormone T3 for depression in patients with bipolar disorder. In this study patients will be randomized to receive T3 or placebo.
Timeline
- Start
- 2008-07
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liothyronine | Unknown | 50 ug | — |